Entinostat, a narrow spectrum histone deacetylase inhibitor, increases MICA expression on tumor cells and NKG2D expression in primary NK cells even in hypoxic conditions, leading to enhancement of cytotoxicity of NK cells against tumor cells [160]. This evidence concerns the gene MICA and neoplasm.